Evaluation of the effect of tumour size on outcomes for patients undergoing adrenalectomy for phaeochromocytoma: international multicentre analysis
Steffane McLennan(University of Alberta), Reza Djafarrian(University Hospital of Geneva), Alison Waghorn(Royal Liverpool and Broadgreen University Hospital NHS Trust), Hannah Anderson(University of Ulster), Fiona Eatock(University of Ulster), Marco Raffaelli(Università Cattolica del Sacro Cuore), A. Ribano(University of Alberta), Alexander Papachristos(Royal North Shore Hospital), Yiğit Türk(Ege University), Byung-Chang Kim(Ulsan College), Vasilis Kosmoliaptsis(Cambridge University Hospitals NHS Foundation Trust), Özer Makay(Ege University), Yanbo Wang(Jilin University), Daryl Gray, Maurizio Iacobone(University of Padua), Richard C. Chaulk(Western University), Sabapathy P. Balasubramanian(Sheffield Teaching Hospitals NHS Foundation Trust), Shuichi Tatarano(Kagoshima University), Isabelle Holscher(Amsterdam University of Applied Sciences), Harry Spiers(Cambridge University Hospitals NHS Foundation Trust), Mark Sywak(Royal North Shore Hospital), Claire Y. Fung(University of Rochester Medical Center), Maciej Śledziński(Gdańsk Medical University), Jiale Zhou(Renji Hospital), Kevin Verhoeff(University of Alberta), David Velázquez‐Fernández(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Francesco Pennestrì(Università Cattolica del Sacro Cuore), Arslan Pannu(Sheffield Teaching Hospitals NHS Foundation Trust), Yu‐Mi Lee(Ulsan College), Fausto Palazzo(Hammersmith Hospital), Alessandro Parente(King's College Hospital NHS Foundation Trust), Leonardo Rossi(Azienda Ospedaliera Universitaria Pisana), Gabriele Materazzi(University of Parma), Tae‐Yon Sung(Ulsan College), Radu Mihai(Churchill Hospital), Anton F. Engelsman(The University of Sydney), Marco Stefano Demarchi(University Hospital of Geneva), Albertas Daukša(Lithuanian University of Health Sciences), Hazel Serrao‐Brown(Royal North Shore Hospital), Yufei Chen(Massachusetts General Hospital), Julie Ann Miller(The Royal Melbourne Hospital), Yonghui Chen(Cedars-Sinai Medical Center), Xiaorong Wu(Mount Vernon Cancer Centre), Hafize Basut Atalay(Ege University), Susannah Shore(Royal Liverpool and Broadgreen University Hospital NHS Trust), Els J.�M. Nieveen van Dijkum(Amsterdam University of Applied Sciences), Andrzej Hellmann(Gdańsk Medical University), Nicola Colucci(Cambridge University Hospitals NHS Foundation Trust), Zhicheng Wang(Jilin University), Chiara Becucci(Azienda Ospedaliera Universitaria Pisana)
Cited by 0
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
A common coding variant in CASP8 is associated with breast cancer risk
|Nature Genetics|2007|612
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2010|587